Sonnet BioTherapeutics Holdings's total assets for Q3 2025 were $2.06M, a decrease of -46.43% from the previous quarter. SONN total liabilities were $5.10M for the fiscal quarter, a 60.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.